Doctor profile · Federal record
Dr. Nauman Moazzam, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Lakewood, CO
- NPI 1407812043
- Accepts Medicare
- MIPS 81.5 / 100 · 2023
- 27 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
11750 W. 2Nd Place Suite 100
Lakewood, CO 802281705
(303) 430-2700
fax (303) 430-2770 - Mailing address
-
7951 E Maplewood Ave, Suite 300
Greenwood Village, CO 801114723
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- February 28, 2014
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Colorado #49295
- Medicaid
- CO #98772244
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1407812043. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
395,831
Distinct HCPCS
10
Medicare allowed
$4,455,422
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 72,000 | 31 | $0 | |
J1453 |
Injection, fosaprepitant, 1 mg | 40,200 | 62 | $0 | |
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 37,260 | 17 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 35,600 | 38 | $53 | |
J9299 |
Injection, nivolumab, 1 mg | 29,180 | 14 | $30 | |
J9025 |
Injection, azacitidine, 1 mg | 27,347 | 13 | $0 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 21,500 | 18 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 17,400 | 28 | $0 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 12,750 | 12 | $1 | |
J9267 |
Injection, paclitaxel, 1 mg | 11,900 | 21 | $0 |
In context: peer comparison
Among 3 peers in Lakewood Hematology & Oncology Physician, average services per provider: 3,032. This provider delivers 131× the peer median.Open Payments
Industry payments received
All-time total
$2,699
Transactions
63
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Taiho Oncology, INC. | 1 | $1,130.00 | |
| Celgene Corporation | 16 | $205.92 | |
| Daiichi Sankyo INC. | 12 | $172.39 | |
| Janssen Biotech, INC. | 5 | $119.37 | |
| TerSera Therapeutics LLC | 4 | $115.89 | |
| Sumitomo Pharma America, INC. | 4 | $97.58 | |
| Pfizer INC. | 4 | $80.17 | |
| GlaxoSmithKline, LLC. | 3 | $76.74 | |
| Erbe USA INC | 1 | $75.00 | |
| Abbvie INC. | 3 | $69.06 | |
| Mirati Therapeutics, INC. | 3 | $65.23 | |
| Astellas Pharma US INC | 2 | $50.58 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $42.98 | |
| Novartis Pharmaceuticals Corporation | 2 | $42.39 | |
| Eisai INC. | 2 | $41.15 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,538
Patients
695
Total drug cost
$2,274,633
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ondansetron Hcl | Generic | 221 | 162 | $2,361 |
| Prochlorperazine Maleate | Generic | 197 | 149 | $4,860 |
| Acyclovir | Generic | 152 | 37 | $2,571 |
| Hydroxyurea | Generic | 121 | 41 | $6,210 |
| Prednisone | Generic | 103 | 49 | $863 |
| Olanzapine | Generic | 96 | 63 | $1,276 |
| Eliquis (Apixaban) | Brand | 93 | 31 | $70,970 |
| Gabapentin | Generic | 84 | 22 | $1,310 |
| Warfarin Sodium | Generic | 84 | 21 | $1,554 |
| Xarelto (Rivaroxaban) | Brand | 75 | 22 | $75,537 |
Frequently asked questions
What is Dr. Nauman Moazzam's medical specialty?
Dr. Nauman Moazzam practices Hematology & Oncology Physician in Lakewood, CO.
Where does Dr. Nauman Moazzam practice?
Dr. Nauman Moazzam practices at 11750 W. 2Nd Place Suite 100, Lakewood, CO 802281705. Office phone: 3034302700.
What is Dr. Nauman Moazzam's NPI?
Dr. Nauman Moazzam's National Provider Identifier (NPI) is 1407812043, issued by NPPES.
Does Dr. Nauman Moazzam accept Medicare assignment?
Yes. Dr. Nauman Moazzam accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Nauman Moazzam commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110). Source: CMS Medicare Physician & Other Practitioners file.